These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

825 related items for PubMed ID: 27765184

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Association of Active and Passive Components of LV Diastolic Filling With Exercise Intolerance in Heart Failure With Preserved Ejection Fraction: Mechanistic Insights From Spironolactone Response.
    Kosmala W, Przewlocka-Kosmala M, Marwick TH.
    JACC Cardiovasc Imaging; 2019 May; 12(5):784-794. PubMed ID: 29248640
    [Abstract] [Full Text] [Related]

  • 3. Effect of If-channel inhibition on hemodynamic status and exercise tolerance in heart failure with preserved ejection fraction: a randomized trial.
    Kosmala W, Holland DJ, Rojek A, Wright L, Przewlocka-Kosmala M, Marwick TH.
    J Am Coll Cardiol; 2013 Oct 08; 62(15):1330-8. PubMed ID: 23916925
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Functional iron deficiency and diastolic function in heart failure with preserved ejection fraction.
    Kasner M, Aleksandrov AS, Westermann D, Lassner D, Gross M, von Haehling S, Anker SD, Schultheiss HP, Tschöpe C.
    Int J Cardiol; 2013 Oct 12; 168(5):4652-7. PubMed ID: 23968714
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Determinants of the beneficial effect of mineralocorticoid receptor antagonism on exercise capacity in heart failure with reduced ejection fraction.
    Dankowski R, Kotwica T, Szyszka A, Przewłocka-Kosmala M, Sacharczuk W, Karolko B, Kobusiak-Prokopowicz M, Mysiak A, Kosmala W.
    Kardiol Pol; 2018 Oct 12; 76(9):1327-1335. PubMed ID: 29862486
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Effects of spironolactone treatment in elderly women with heart failure and preserved left ventricular ejection fraction.
    Kurrelmeyer KM, Ashton Y, Xu J, Nagueh SF, Torre-Amione G, Deswal A.
    J Card Fail; 2014 Aug 12; 20(8):560-8. PubMed ID: 24905296
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Effects of mineralocorticoid receptor antagonists on left ventricular diastolic function, exercise capacity, and quality of life in heart failure with preserved ejection fraction: a meta-analysis of randomized controlled trials.
    Fukuta H, Goto T, Wakami K, Kamiya T, Ohte N.
    Heart Vessels; 2019 Apr 12; 34(4):597-606. PubMed ID: 30315496
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Association between long-term prescription of aldosterone antagonist and the progression of heart failure with preserved ejection fraction in hypertensive patients.
    Gu J, Fan YQ, Han ZH, Fan L, Bian L, Zhang HL, Xu ZJ, Yin ZF, Xie YS, Zhang JF, Wang CQ.
    Int J Cardiol; 2016 Oct 01; 220():56-60. PubMed ID: 27372043
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 42.